Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P970004/S458

InterStim Therapy System Verify Evaluation System

Medtronic Neuromodulation · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONP970004/S458

What did the FDA decide?

The FDA record lists PMA supplement P970004/S458 for the InterStim Therapy System under applicant Medtronic Neuromodulation, device category stimulator, electrical, implantable, for incontinence, with product code EZW. It is a 30-Day Notice, and its stated purpose is the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers. The record gives no further description of how that verification step is performed or what it verifies.

The supplement identifier ties this notice to original PMA P970004, but a supplement is not a new approval of the whole system, and a manufacturing notice filed under a process-change reason is not an original PMA. The record does not state whether the verification step affects device performance, safety or clinical effectiveness, and the notice's reported purpose is not independent proof of those outcomes.

The supplied fields also lack details on the recharger models themselves and on any manufacturing sites or suppliers involved, so the scope of the change remains limited to the wording of the statement.

FDA approval order statement

the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P970004/S458
Regulatory pathway
PMA supplement
Product code
EZW
Decision code
OK30
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implantable, for incontinence.

Product code
EZW
FDA device class
3

For the original device and its historical approval scope, see PMA P970004. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P970004 · Original PMA

    MEDTRONIC INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL

  2. P970004/S458 received

    Application receipt date recorded by FDA.

  3. P970004/S458 · FDA decision

    30-Day Notice

  4. P970004/S457 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  5. P970004/S459 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P970004/S460 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800), (SNS Urinary Neurostimulator I

Timeline entries are records held by MedtechLedger for P970004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P970004

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records